Avails Medical, Inc.

Avails Medical, Inc. is an in vitro diagnostics company founded in 2013 by Stanford University alumni and based in Menlo Park, California. The company specializes in rapid, automated antibiotic susceptibility testing (AST) technologies aimed at addressing antimicrobial resistance and improving outcomes for sepsis patients. Their innovative all-electrical biosensor platform streamlines the testing process by eliminating manual culturing steps, allowing for faster pathogen quantification and susceptibility testing directly from human specimens. The flagship product, the eQUANT™ System, is an FDA-cleared electronic biosensor that provides results in approximately 70 minutes, significantly reducing turnaround time for testing common gram-negative bacteria. This system is designed for easy integration into laboratory workflows and supports timely diagnostics, which can lead to better patient outcomes and lower healthcare costs. Each minute of diagnostic delay increases sepsis mortality risk; Avails Medical's rapid AST platform addresses the critical clinical need for accelerated antimicrobial susceptibility identification in blood culture specimens, with documented multicenter validation.